DSECT/DSEN Seminar Series: Drug Benefits Management: A Focus on Cancer

Public drug funders in Canada face common issues of value, affordability and sustainability in their drug programs. Oncology in particular is a field where new therapies have very high drug costs yet where there may be multiple questions about a drug’s effectiveness, safety and value at the time of market launch.

This presentation by Scott Gavura will provide an overview of the current drug funding decision-making processes with a focus on the pathways established for cancer drugs. The sustainability challenge facing the cancer system will be described and recent initiatives will be summarized.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
DSECT/DSEN Seminar Series: Drug Benefits Management: A Focus on Cancer
css.php